{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:27:44Z","timestamp":1769732864089,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.tcm.2023.11.001","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T02:02:11Z","timestamp":1700532131000},"page":"416-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Selected highlights in the updated treatment of hypertension"],"prefix":"10.1016","volume":"34","author":[{"given":"Daniel","family":"Creegan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6530-5479","authenticated-orcid":false,"given":"John W.","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10304","key":"10.1016\/j.tcm.2023.11.001_bib0001","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","journal-title":"Lancet"},{"issue":"9349","key":"10.1016\/j.tcm.2023.11.001_bib0002","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Prospective studies C. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2023.11.001_bib0003","article-title":"A linear and non-linear mendelian randomization analysis of the association between diastolic blood pressure and cardiovascular events: the j curve revisited","author":"Arvanitis","year":"2020","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.tcm.2023.11.001_bib0004","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jamacardio.2020.1731","article-title":"Association of normal systolic blood pressure level with cardiovascular disease in the absence of risk factors","volume":"5","author":"Whelton","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.tcm.2023.11.001_bib0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2147\/IBPC.S286957","article-title":"The diastolic blood pressure j-curve in hypertension management: links and risk for cardiovascular disease","volume":"14","author":"Gaffney","year":"2021","journal-title":"Integr Blood Press Control"},{"issue":"35","key":"10.1016\/j.tcm.2023.11.001_bib0006","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1093\/eurheartj\/ehac432","article-title":"Harmonization of the american college of cardiology\/american heart association and european society of cardiology\/european society of hypertension blood pressure\/hypertension guidelines","volume":"43","author":"Whelton","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.tcm.2023.11.001_bib0007","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.tcm.2023.11.001_bib0008","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/M13-2981","article-title":"Evidence supporting a systolic blood pressure goal of less than 150mm Hg in patients aged 60 years or older: the minority view","volume":"160","author":"Wright","year":"2014","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.tcm.2023.11.001_bib0009","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ije\/14.1.32","article-title":"Sick individuals and sick populations","volume":"14","author":"Rose","year":"1985","journal-title":"Int J Epidemiol"},{"issue":"22","key":"10.1016\/j.tcm.2023.11.001_bib0010","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Group","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tcm.2023.11.001_bib0011","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1161\/HYPERTENSIONAHA.120.15866","article-title":"Impact of therapeutic inertia on long-term blood pressure control: a monte carlo simulation study","volume":"77","author":"Augustin","year":"2021","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.tcm.2023.11.001_bib0012","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/jamainternmed.2020.5028","article-title":"Concordance between blood pressure in the systolic blood pressure intervention trial and in routine clinical practice","volume":"180","author":"Drawz","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1016\/j.tcm.2023.11.001_bib0013","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jamacardio.2022.3345","article-title":"Longer-term all-cause and cardiovascular mortality with intensive blood pressure control: a secondary analysis of a randomized clinical trial","volume":"7","author":"Jaeger","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"16","key":"10.1016\/j.tcm.2023.11.001_bib0014","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.jacc.2016.07.754","article-title":"Diastolic blood pressure, subclinical myocardial damage, and cardiac events: implications for blood pressure control","volume":"68","author":"McEvoy","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.tcm.2023.11.001_bib0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/CIRCULATIONAHA.117.030848","article-title":"Influence of baseline diastolic blood pressure on effects of intensive compared with standard blood pressure control","volume":"137","author":"Beddhu","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2023.11.001_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.amepre.2023.04.011","article-title":"The 2017 american college of cardiology\/american heart association hypertension guideline and blood pressure in older adults","author":"Wang","year":"2023","journal-title":"Am J Prev Med"},{"issue":"14","key":"10.1016\/j.tcm.2023.11.001_bib0017","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.tcm.2023.11.001_bib0018","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.2023.0713","article-title":"Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial","volume":"329","author":"Azizi","year":"2023","journal-title":"JAMA"},{"issue":"10234","key":"10.1016\/j.tcm.2023.11.001_bib0019","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0140-6736(20)30554-7","article-title":"Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial","volume":"395","author":"B\u00f6hm","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.tcm.2023.11.001_bib0020","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcin.2019.10.061","article-title":"The reduce htn: reinforce: randomized, sham-controlled trial of bipolar radiofrequency renal denervation for the treatment of hypertension","volume":"13","author":"Weber","year":"2020","journal-title":"JACC Cardiovas Interv"},{"issue":"10137","key":"10.1016\/j.tcm.2023.11.001_bib0021","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/S0140-6736(18)30951-6","article-title":"Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the spyral htn-on med proof-of-concept randomised trial","volume":"391","author":"Kandzari","year":"2018","journal-title":"Lancet"},{"issue":"42","key":"10.1016\/j.tcm.2023.11.001_bib0022","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1093\/eurheartj\/ehz118","article-title":"Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the global symplicity registry","volume":"40","author":"Mahfoud","year":"2019","journal-title":"Eur Heart J."},{"key":"10.1016\/j.tcm.2023.11.001_bib0023","doi-asserted-by":"crossref","unstructured":"Rader F., Kirtane A.J., Wang Y., Daemen J., Lurz P., Sayer J., et al. Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2022;18(8):e677\u2013e85.","DOI":"10.4244\/EIJ-D-22-00305"},{"issue":"21","key":"10.1016\/j.tcm.2023.11.001_bib0024","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022429","article-title":"Comparison of long-term outcomes for responders versus non-responders following renal denervation in resistant hypertension","volume":"10","author":"Fengler","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"20","key":"10.1016\/j.tcm.2023.11.001_bib0025","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.jacc.2022.08.802","article-title":"Cardiovascular risk reduction after renal denervation according to time in therapeutic systolic blood pressure range","volume":"80","author":"Mahfoud","year":"2022","journal-title":"J Am Coll Cardiol."},{"issue":"16","key":"10.1016\/j.tcm.2023.11.001_bib0026","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/CIRCULATIONAHA.120.050371","article-title":"Blood pressure effects of sodium reduction: dose-response meta-analysis of experimental studies","volume":"143","author":"Filippini","year":"2021","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.tcm.2023.11.001_bib0027","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/eurheartj\/ehs409","article-title":"Salt intake and cardiovascular disease: why are the data inconsistent?","volume":"34","author":"O'Donnell","year":"2013","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.tcm.2023.11.001_bib0028","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s13668-021-00383-z","article-title":"Sodium and health: old myths and a controversy based on denial","volume":"11","author":"Cappuccio","year":"2022","journal-title":"Curr Nutr Rep"},{"issue":"17","key":"10.1016\/j.tcm.2023.11.001_bib0029","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1001\/jama.2011.574","article-title":"Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion","volume":"305","author":"Stolarz-Skrzypek","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.tcm.2023.11.001_bib0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2109794","article-title":"24 hour urinary sodium and potassium excretion and cardiovascular risk","volume":"386","author":"Ma","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2023.11.001_bib0031","article-title":"Salt restriction for treatment of hypertension \u2013 current state and future directions","volume":"38","author":"Nolan","year":"2023","journal-title":"Curr Opin Cardiol"},{"issue":"4","key":"10.1016\/j.tcm.2023.11.001_bib0032","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41591-023-02286-8","article-title":"Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial","volume":"29","author":"Yuan","year":"2023","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.tcm.2023.11.001_bib0033","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1056\/NEJMoa2105675","article-title":"Effect of salt substitution on cardiovascular events and death","volume":"385","author":"Neal","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.tcm.2023.11.001_bib0034","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1056\/NEJMoa0907355","article-title":"Projected effect of dietary salt reductions on future cardiovascular disease","volume":"362","author":"Bibbins-Domingo","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.tcm.2023.11.001_bib0035","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/bmjnph-2021-000408","article-title":"Reducing daily salt intake in China by 1g could prevent almost 9 million cardiovascular events by 2030: a modelling study","volume":"5","author":"Tan","year":"2022","journal-title":"BMJ Nutr Prev Health"},{"issue":"14","key":"10.1016\/j.tcm.2023.11.001_bib0036","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1717250","article-title":"A cluster-randomized trial of blood-pressure reduction in black barbershops","volume":"378","author":"Victor","year":"2018","journal-title":"N Engl J Med"},{"issue":"10339","key":"10.1016\/j.tcm.2023.11.001_bib0037","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0140-6736(22)00325-7","article-title":"A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial","volume":"399","author":"Sun","year":"2022","journal-title":"Lancet"},{"issue":"10380","key":"10.1016\/j.tcm.2023.11.001_bib0038","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(22)02603-4","article-title":"Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial","volume":"401","author":"He","year":"2023","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.tcm.2023.11.001_bib0039","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jama.2013.108769","article-title":"Improved blood pressure control associated with a large-scale hypertension program","volume":"310","author":"Jaffe","year":"2013","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.tcm.2023.11.001_bib0040","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jama.2023.17087","article-title":"A new dawn for aldosterone as a therapeutic target in hypertension","volume":"330","author":"Williams","year":"2023","journal-title":"JAMA"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105017382300097X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105017382300097X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T23:02:54Z","timestamp":1722898974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105017382300097X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S105017382300097X"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2023.11.001","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selected highlights in the updated treatment of hypertension","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2023.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}